These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 3717176)

  • 21. Handling antineoplastic-drug admixtures at cancer centers: practices and pharmacist attitudes.
    Gregoire RE; Segal R; Hale KM
    Am J Hosp Pharm; 1987 May; 44(5):1090-5. PubMed ID: 3605119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacy implications of the revised OSHA Hazard Communication Standard.
    Myers CE
    Am J Hosp Pharm; 1989 May; 46(5):990-1. PubMed ID: 2729307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Safe handling of cytotoxic drugs. Work practice for personnel dealing with cytotoxic drugs].
    Imamura S; Hardy A
    Kango; 1992 Jun; 44(6):52-9. PubMed ID: 1305261
    [No Abstract]   [Full Text] [Related]  

  • 24. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 25. Documentation forms for monitoring occupational surveillance of healthcare workers who handle cytotoxic drugs.
    Parillo VL
    Oncol Nurs Forum; 1994; 21(1):115-20. PubMed ID: 8139995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost of implementing Veterans Administration directives for handling antineoplastic agents.
    Murphy CP; Goldspiel BR; Koeller J
    Am J Hosp Pharm; 1987 Apr; 44(4):788-91. PubMed ID: 3578312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk perception and self-assessment of exposure to antineoplastic agents in a group of nurses and pharmacists].
    Vollono C; Badoni G; Petrelli G
    G Ital Med Lav Ergon; 2002; 24(1):49-55. PubMed ID: 11892417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of a hospital policy for health care workers exposed to hepatitis or the human immunodeficiency virus.
    Fahrner R
    Am J Hosp Pharm; 1993 Feb; 50(2):269-75. PubMed ID: 8480782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive program for handling hazardous drugs.
    Arrington DM; McDiarmid MA
    Am J Hosp Pharm; 1993 Jun; 50(6):1170-4. PubMed ID: 8517456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceuticals as hospital hazards: managing the risks.
    McDiarmid MA; Gurley HT; Arrington D
    J Occup Med; 1991 Feb; 33(2):155-8. PubMed ID: 2016654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Centralized preparations of cytostatic agents: a method for quality control].
    Wernli M; Bögli F; Mühlebach S; Conen D
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1962-5. PubMed ID: 7973528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Workplace violence: Occupational Safety and Health Administration guidelines for workers in health care and social services.
    Trapé M
    Conn Med; 1998 Jun; 62(6):333-6. PubMed ID: 9675992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel.
    Valanis BG; Vollmer WM; Labuhn KT; Glass AG
    Am J Hosp Pharm; 1993 Mar; 50(3):455-62. PubMed ID: 8442461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic drug handlers--monitoring in the occupational health setting.
    DesRoches P
    AAOHN J; 2003 Mar; 51(3):106-8. PubMed ID: 12670096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of the Occupational Safety and Health Administration's bloodborne pathogen standard for the occupational health professional.
    Udasin IG; Gochfeld M
    J Occup Med; 1994 May; 36(5):548-55. PubMed ID: 8027880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS and hepatitis B: protecting health care employees.
    Chaff L; Blevins-Doll C
    J Healthc Prot Manage; 1989; 6(1):92-101. PubMed ID: 10296678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safe handling of antineoplastic drugs.
    Harrison BR
    Top Hosp Pharm Manage; 1994 Jul; 14(2):1-10. PubMed ID: 10136200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Summary of recommendations for a rational implementation of the ministry of health guidelines on the prevention of occupational risks in handling antineoplastic agents].
    Gruppo di Lavoro dell'Associazione Italiana di Medicina Preventiva dei Lavoratori della Sanità
    Med Lav; 2001; 92(2):137-48. PubMed ID: 11441591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical surveillance of the lead exposed worker. Current guidelines.
    Hipkins KL; Materna BL; Kosnett MJ; Rogge JW; Cone JE
    AAOHN J; 1998 Jul; 46(7):330-9. PubMed ID: 9748913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Veterans Administration medical center policies and procedures for handling injectable antineoplastic drugs.
    Moody DG
    Am J Hosp Pharm; 1984 May; 41(5):916-9. PubMed ID: 6731452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.